Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Rigel Pharmaceuticals)"
Count: 32
Selected: 0
NCT IDTitle
NCT06161974Study of Olutasidenib and Temozolomide in HGG
NCT05308264Study of R289 in Participants With Lower-risk Myelodysplastic Syndromes (LR MDS)
NCT04904276Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy
NCT04629703Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects
NCT04138927A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
NCT03764618A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA
NCT03363334Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP
NCT02612558A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)
NCT02433236Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy
NCT02112838Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy
NCT02077192Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
NCT02076412A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
NCT02076399A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
NCT02040623Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)
NCT01900249To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
NCT01733992A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease
NCT01597050Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
NCT01591044A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
NCT00798096Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma
NCT00752999Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus
NCT00706342Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)
NCT00665925Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis
NCT00665626Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3)
NCT00446095Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma
NCT00326339Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1)
NCT001150897 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis
NCT04543279Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia
NCT05848258An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis
NCT05040698Study of the Effect of Fostamatinib Upon Cutaneous Inflammation in the Setting of Hidradenitis Suppurativa
NCT03246074Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer
NCT06233110Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
NCT04581954Inflammatory Signal Inhibitors for COVID-19 (MATIS)